Mylan, Pfizer Escape Suit Over EpiPen Pricing
An EpiPen direct purchaser's decision to drop a proposed class action, alleging pharmaceutical companies including Mylan Inc. and Pfizer Inc. stifled competition in an effort to drive up prices for their...To view the full article, register now.
Already a subscriber? Click here to view full article